Automated Cell Biology Systems Market is expected to reach US$ 33.5 Billion by end of 2032 at a CAGR of 9.0%

According to Future Market Insights’ most recent industry report, the global automated cell biology systems market size stands at US$ 14.1 Billion in 2022 and is expected to rise at a CAGR close to 9.0% over the forecast period, with an anticipated worth of around US$ 33.5 Billion in 2032.

The development of powerful new technologies and applications is made possible by laboratory automation, a major force in the biotechnology sector. Automation in research and production, specifically in the area of personalized therapies, is a requirement for achieving cost effectiveness and widespread accessibility of customized treatments.

Over the last two decades, the biotechnology sector has paid increasingly more attention to laboratory automation. With the development of digitalization and Industry 4.0, biotech automation has spread from its initial focus on analytical laboratories to now being used widely throughout the industry.

Request a Sample to Obtain Analysis and Comprehensive Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15816

In fact, it is widely acknowledged that many aspects of future medicine would only be possible with the help of automation. These include automated complicated data processing for precision medicine, healthcare robotics for surgery and care, automated production, and sophisticated supply chains for innovative therapeutics.

This is especially true for cell-based personalized medicines, which depend on automation to lower costs and increase accessibility. Whether for personalized drug research or autologous cell treatments, patient-derived cell multiplication is labor-intensive and characterized by substantial batch-to-batch variability.

Additionally, because individual batch sizes are small, personalized medicine requires a high overall throughput in order to be economically viable. These factors pose a demand for automated cell biology systems, thus propelling the overall market value over the forecast period.

Key Takeaways from Market Study

• Automated cell counters (single function) are the leading segment as product, and hold approximately 34.6% market share in 2021, as they provide accurate cell counts.
• Drug development applications hold a market share of around 35.4% in 2021, owed to robust growth of biopharmaceutical industry.
• Infinite cell line cultures account for around 76.2% in 2021, as they are easy to culture than primary cell cultures.
• Biopharmaceutical companies as prime end users hold a share of around 27.4% in 2021, owed to growing CMO/CDMO activities for drug manufacturing.
• North America holds a dominant share of 37.4% in 2021, owed to a high economic output in the region.

“Rising Demand for Personalized Medicine, and Growth in Total Lab Automation Techniques will Propel Overall Market Growth,” says an analyst of Future Market Insights. 

For critical insights on this market, request to ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15816

Market Competition

Key Players:

• Thermo Fisher Scientific
• Corning Incorporated
• Merck KGaA
• Lonza
• Sartorius AG
• Hitachi. Ltd
• Nanoentek
• ChemoMetec
• Danaher corporation
• Others

Automated cell biology system manufacturers have been substantially investing in research to offer long-term solutions for both the biopharmaceutical and packaging industries. Players in the automated cell biology systems market are also focusing on innovations and alliances to strengthen their market position.

For instance:

• In October 2022, Thermo Fisher developed a closed and automated cell separation and bead removal system to aid in the advancement of cell therapy manufacturing.
• Merck will expand bioprocessing capabilities by purchasing Lonza’s MAST® Platform, a prominent automated bioreactor sampling technology, in April 2022.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the automated cell biology systems market in its latest study, presenting a historical demand assessment of 2012 to 2021 and projections for 2022 to 2032. The global automated cell biology systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/15816

Key Market Segments Covered in Automated Cell Biology Systems Industry Research

By Product:

• Cell Culture Process Automatization Instrument or Robot (Multiple Function)
• Automated Bioreactor (Single or Multiple Function)
• Automated Cell Culture Media Exchange System (Single Function)
• Automated Culture Media Analyzer (Single Function)
• Automated Cell Wash-and-Concentrate System (Single Function)
• Automated Cell Counter (Single Function)
• Automated Fill And Finish System (Single Function)
• Automated Cell Storage Equipment (Single Function)
• Management Software

By Cell Culture:

• Finite Cell Line Cultures
• Infinite Cell Line Cultures

By Application:

• Cell Therapy
• Drug Development
• Stem Cell Research
• Regenerative Medicine

By End User:

• Mega Pharmaceutical companies
• Biopharmaceutical companies
• CDMOs/CMOs
• Research organizations
• Academic institutes

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs